Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by VICENTE-MASTELLARI, A.
Right arrow Articles by YOUNG, R. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by VICENTE-MASTELLARI, A.
Right arrow Articles by YOUNG, R. V.
(Chest. 1957;31:74-83.)
© 1957 American College of Chest Physicians

Evaluation of Results After the Administration of Drugs in the Presence of Resistant Mycobacterium Tuberculosis

AMADEO VICENTE-MASTELLARI M.D., F.C.C.P.1 and RODOLFO V. YOUNG M.D., F.C.C.P.2

1 Chief Chest Service, Gorgas Hospital. Professor of Phthisiology, University of Panama, Medical School.
2 Staff Chest Service, Gorgas Hospital. Assistant Professor of Phthisiology, University of Panama Medical School.

1. Two hundred and seventy patients with pulmonary tuberculosis admitted to the Chest Service of Gorgas Hospital from June 1949 through December 1954 were evaluated.

2. Clinical, radiological and bacteriological results were analyzed on those patients that developed resistant bacilli to the antituberculous drugs.

3. The fact that the development of resistance occurs earlier when these agents are administered alone than when given combined with one or more is again confirmed; therefore, from a purely medical standpoint, the use of one drug alone, including viomycin is not to be recommended.

4. Once resistance appears, there is no clinical, radiological, or bacteriological improvement that can be attributed as due to the chemo-antibiotics agents.

5. Even in the presence of resistant organisms, the chemo-therapeutic agents prevent extensions and disseminations as the result of surgical interventions and they stabilize the lesions on the so called "good chronics."

6. Toxicity to the drugs was found in four (1.4 per cent) of the cases. Only one had permanent damage.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1957 by the American College of Chest Physicians.